본문으로 건너뛰기
← 뒤로

Risk factors of postoperative hypoparathyroidism after total thyroidectomy in pediatric patients with thyroid cancer.

1/5 보강
Annals of pediatric endocrinology & metabolism 2023 Vol.28(1) p. 26-33
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
98 patients younger than 20 years who were diagnosed with thyroid cancer after T T during 1990-2018 and followed for more than 2 years at Seoul National University Hospital.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] HypoPTH occurred in 43.9% of pediatric thyroid cancer patients after TT in this study. Among them, one-third of patients continued active vitamin D medication for more than 2 years, which was predicted by young age and low preoperative calcium level.

Choe Y, Lee YJ, Shin CH, Chung EJ, Lee YA

📝 환자 설명용 한 줄

[PURPOSE] Hypoparathyroidism (hypoPTH) is the most common complication following thyroidectomy.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P=0.013
  • p-value P=0.028

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Choe Y, Lee YJ, et al. (2023). Risk factors of postoperative hypoparathyroidism after total thyroidectomy in pediatric patients with thyroid cancer.. Annals of pediatric endocrinology & metabolism, 28(1), 26-33. https://doi.org/10.6065/apem.2244044.022
MLA Choe Y, et al.. "Risk factors of postoperative hypoparathyroidism after total thyroidectomy in pediatric patients with thyroid cancer.." Annals of pediatric endocrinology & metabolism, vol. 28, no. 1, 2023, pp. 26-33.
PMID 35798302

Abstract

[PURPOSE] Hypoparathyroidism (hypoPTH) is the most common complication following thyroidectomy. We investigated the frequency and risk factors of hypoPTH after total thyroidectomy (TT) in pediatric patients with thyroid cancer.

[METHODS] This retrospective study included 98 patients younger than 20 years who were diagnosed with thyroid cancer after T T during 1990-2018 and followed for more than 2 years at Seoul National University Hospital. HypoPTH was defined as receiving active vitamin D (1-hydroxycholecalciferol or 1,25-dihydroxycholecalciferol) after surgery.

[RESULTS] The study included 27 boys (27.6%) and 71 girls (72.4%). The mean age at diagnosis was 14.9±3.7 years. HypoPTH occurred in 43 patients (43.9%). Twenty-one patients (21.4%) discontinued active vitamin D less than 6 months after surgery, while 14 (14.3%) continued active vitamin D for more than 2 years. Tumor multifocality (odds ratio [OR], 3.7 vs. single tumor; P=0.013) and preoperative calcium level (OR, 0.2; P=0.028) were independent predictors of hypoPTH immediately after TT. In addition, age (OR, 0.8; P=0.011) and preoperative calcium level (OR, 0.04; P=0.014) significantly decreased the risk for persistent hypoPTH requiring active vitamin D for more than 2 years.

[CONCLUSION] HypoPTH occurred in 43.9% of pediatric thyroid cancer patients after TT in this study. Among them, one-third of patients continued active vitamin D medication for more than 2 years, which was predicted by young age and low preoperative calcium level.